$BLFS
BIOLIFE SOLUTIONS INC

2019 Q4 Form 10-Q Financial Statement

#000143774919022475 Filed on November 12, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $8.300M $6.604M $5.293M
YoY Change 52.01% 24.77% 78.61%
Cost Of Revenue $3.070M $2.094M $1.606M
YoY Change 79.53% 30.39% 46.57%
Gross Profit $5.230M $4.520M $3.687M
YoY Change 39.47% 22.59% 97.41%
Gross Profit Margin 63.01% 68.44% 69.66%
Selling, General & Admin $3.980M $3.598M $2.180M
YoY Change 66.53% 65.05% 35.66%
% of Gross Profit 76.1% 79.6% 59.13%
Research & Development $750.0K $1.032M $312.0K
YoY Change 141.94% 230.77% 6.45%
% of Gross Profit 14.34% 22.83% 8.46%
Depreciation & Amortization $960.0K $114.0K $80.00K
YoY Change 860.0% 42.5% 0.0%
% of Gross Profit 18.36% 2.52% 2.17%
Operating Expenses $5.860M $7.376M $4.098M
YoY Change 117.04% 79.99% 115.68%
Operating Profit -$630.0K -$772.0K $1.195M
YoY Change -160.0% -164.6% -3794.54%
Interest Expense $90.00K $1.000K $1.000K
YoY Change -160.0% 0.0% -7.15%
% of Operating Profit 0.08%
Other Income/Expense, Net -$12.84M $11.04M -$25.66M
YoY Change -54.58% -143.03% 8860.34%
Pretax Income -$13.78M $10.27M $1.231M
YoY Change -49.67% 734.2% -486.23%
Income Tax -$1.540M $0.00
% Of Pretax Income 0.0%
Net Earnings -$12.24M $10.27M -$24.47M
YoY Change -55.3% -141.97% 7576.06%
Net Earnings / Revenue -147.47% 155.5% -462.21%
Basic Earnings Per Share $0.42 -$1.42
Diluted Earnings Per Share -$593.3K $0.35 -$1.42
COMMON SHARES
Basic Shares Outstanding 20.45M 19.74M 17.27M
Diluted Shares Outstanding 25.34M 17.27M

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.400M $21.20M $100.0K
YoY Change -79.15% 21100.0% -96.43%
Cash & Equivalents $6.448M $21.21M $32.38M
Short-Term Investments $100.0K
Other Short-Term Assets $1.300M $900.0K $32.60M
YoY Change 225.0% -97.24% 10766.67%
Inventory $10.97M $5.694M $2.911M
Prepaid Expenses
Receivables $5.345M $4.313M $2.699M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.11M $32.07M $38.29M
YoY Change -35.81% -16.25% 498.27%
LONG-TERM ASSETS
Property, Plant & Equipment $5.572M $2.136M $1.267M
YoY Change 322.44% 68.59% 15.18%
Goodwill $33.64M $28.34M
YoY Change
Intangibles $21.98M $16.06M
YoY Change
Long-Term Investments $1.000M $6.857M
YoY Change -85.42% 389.79%
Other Assets $100.0K $0.00 $0.00
YoY Change
Total Long-Term Assets $68.70M $51.72M $8.160M
YoY Change 769.33% 533.85% 226.4%
TOTAL ASSETS
Total Short-Term Assets $24.11M $32.07M $38.29M
Total Long-Term Assets $68.70M $51.72M $8.160M
Total Assets $92.82M $83.79M $46.45M
YoY Change 104.14% 80.39% 421.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.119M $1.570M $1.090M
YoY Change 333.19% 44.04% 172.5%
Accrued Expenses $301.0K $642.0K $162.0K
YoY Change -75.31% 296.3% -67.6%
Deferred Revenue $324.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $7.669M $5.014M $2.095M
YoY Change 295.51% 139.33% 90.45%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.000K $3.000K $38.00K
YoY Change -98.95% -92.11% -25.83%
Total Long-Term Liabilities $4.000K $3.000K $38.00K
YoY Change -98.95% -92.11% -25.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.669M $5.014M $2.095M
Total Long-Term Liabilities $4.000K $3.000K $38.00K
Total Liabilities $49.36M $48.60M $52.94M
YoY Change 60.08% -8.21% 3014.35%
SHAREHOLDERS EQUITY
Retained Earnings -$100.1M -$103.0M -$119.3M
YoY Change 1.68% -13.61%
Common Stock $143.5M $138.2M $112.8M
YoY Change 26.97% 22.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.45M $35.19M -$6.495M
YoY Change
Total Liabilities & Shareholders Equity $92.82M $83.79M $46.45M
YoY Change 104.14% 80.39% 421.9%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$12.24M $10.27M -$24.47M
YoY Change -55.3% -141.97% 7576.06%
Depreciation, Depletion And Amortization $960.0K $114.0K $80.00K
YoY Change 860.0% 42.5% 0.0%
Cash From Operating Activities -$1.010M $1.140M $810.0K
YoY Change -271.19% 40.74% 1057.14%
INVESTING ACTIVITIES
Capital Expenditures -$1.520M -$540.0K -$280.0K
YoY Change 850.0% 92.86% 2700.0%
Acquisitions
YoY Change
Other Investing Activities -$12.50M $250.0K -$5.000M
YoY Change -105.0%
Cash From Investing Activities -$14.02M -$290.0K -$5.280M
YoY Change 8662.5% -94.51% 52700.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 270.0K 740.0K 22.68M
YoY Change -112.62% -96.74% 4940.0%
NET CHANGE
Cash From Operating Activities -1.010M 1.140M 810.0K
Cash From Investing Activities -14.02M -290.0K -5.280M
Cash From Financing Activities 270.0K 740.0K 22.68M
Net Change In Cash -14.76M 1.590M 18.21M
YoY Change 763.16% -91.27% 3470.59%
FREE CASH FLOW
Cash From Operating Activities -$1.010M $1.140M $810.0K
Capital Expenditures -$1.520M -$540.0K -$280.0K
Free Cash Flow $510.0K $1.680M $1.090M
YoY Change -32.0% 54.13% 1262.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Small Business
EntitySmallBusiness
true
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
0
CY2018Q3 blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
32000
blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
95000
CY2019Q3 blfs Amortization Of Deferred Rent
AmortizationOfDeferredRent
0
blfs Amortization Of Operating Lease Liability
AmortizationOfOperatingLeaseLiability
132000
blfs Amortization Of Operating Lease Liability
AmortizationOfOperatingLeaseLiability
CY2019Q3 blfs Assets Held For Rent
AssetsHeldForRent
2976000
CY2019Q3 blfs Assets Held For Rent Noncurrent
AssetsHeldForRentNoncurrent
2976000
CY2018Q4 blfs Assets Held For Rent Noncurrent
AssetsHeldForRentNoncurrent
CY2019Q3 blfs Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
87500
blfs Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
116500
CY2019Q3 blfs Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
4.75
blfs Class Of Warrant Or Right Exercised During Period Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
4.75
CY2018Q4 blfs Landlordfunded Leasehold Improvements Accumulated Amortization
LandlordfundedLeaseholdImprovementsAccumulatedAmortization
757000
CY2018Q4 blfs Landlordfunded Leasehold Improvements Gross
LandlordfundedLeaseholdImprovementsGross
1125000
CY2018Q4 blfs Landlordfunded Leasehold Improvements Net
LandlordfundedLeaseholdImprovementsNet
368000
blfs Payments On Equipment Financing
PaymentsOnEquipmentFinancing
12000
blfs Payments On Equipment Financing
PaymentsOnEquipmentFinancing
8000
blfs Payments To Acquire Assets Held For Rent
PaymentsToAcquireAssetsHeldForRent
453000
blfs Payments To Acquire Assets Held For Rent
PaymentsToAcquireAssetsHeldForRent
blfs Proceeds From Exercise Of Common Stock Options And Warrants
ProceedsFromExerciseOfCommonStockOptionsAndWarrants
1394000
blfs Proceeds From Exercise Of Common Stock Options And Warrants
ProceedsFromExerciseOfCommonStockOptionsAndWarrants
11724000
blfs Receivables Converted To Equity Investment
ReceivablesConvertedToEquityInvestment
blfs Receivables Converted To Equity Investment
ReceivablesConvertedToEquityInvestment
150000
CY2019Q3 blfs Shippers And Related Components In Production
ShippersAndRelatedComponentsInProduction
1450000
CY2019Q3 blfs Shippers Placed In Service Gross
ShippersPlacedInServiceGross
1577000
CY2019Q3 blfs Shippers Placed In Service Net
ShippersPlacedInServiceNet
1526000
CY2019Q3 blfs Shippres Placed In Service Accumulated Depreciation
ShippresPlacedInServiceAccumulatedDepreciation
51000
CY2018Q4 blfs Straightline Rent Adjustment
StraightlineRentAdjustment
111000
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000834365
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20452205
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
BIOLIFE SOLUTIONS INC
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
blfs
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1570000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
720000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4313000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3045000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
642000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
91000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2298000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2328000
CY2019Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
137392000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
114160000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1907000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
654000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1131000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
383000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
654000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
383000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1907000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1131000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
68000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
465000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
CY2019Q3 us-gaap Assets
Assets
84228000
CY2018Q4 us-gaap Assets
Assets
45467000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
32067000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
37564000
CY2019Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
291000
CY2018Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
538000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
CY2019Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
371000
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
CY2019Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1560000
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
10108000
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
CY2019Q3 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
10108000
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
19932000
CY2018Q3 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
146000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
49000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30657000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6663000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21205000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32381000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9452000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
25718000
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.33
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.35
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3963505
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4080005
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20344825
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18547406
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20344825
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18547406
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
20000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
19000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk and business risk</div></div></div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33%</div></div> of our product revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div></div> customers and in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%</div> of our revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customer. In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">41%</div> of our product revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers and in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28%</div> of our revenue from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> customers. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> other customer accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of revenue in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> In the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">81%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">90%,</div> of our revenue from CryoStor products, respectively. In each of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> we derived approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">84%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">88%,</div> of our revenue from CryoStor products, respectively. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> of total gross accounts receivable. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">71%</div> of total gross accounts receivable.&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Revenue from customers located in Canada represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17%</div> and in all other foreign countries represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14%</div> of total revenue during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019, </div>respectively. Revenue from customers located in Canada represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%</div> and in all other foreign countries represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of total revenue during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2018, </div>respectively. All revenue from foreign customers is denominated in United States dollars.</div></div></div></div></div></div></div></div></div></div>
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2084000
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1606000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5690000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4507000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
53000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
CY2018Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
479000
CY2019Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
130000
CY2019Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
349000
CY2019Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
36000
CY2018Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
36000
us-gaap Depreciation
Depreciation
373000
us-gaap Depreciation
Depreciation
245000
CY2019Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
CY2018Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
80000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
279000
CY2018Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
80000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1576000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
998000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
20000
CY2019Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
14000
CY2018Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
CY2019Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6000
CY2018Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
CY2019Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
22000
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
3000
CY2019Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
15000
CY2019Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
4000
CY2019Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2000
CY2019Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.081
CY2019Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y146D
CY2019Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
588000
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
706000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-13000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2019Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-13000
CY2018Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2258000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1455000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6579000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4199000
CY2019Q3 us-gaap Goodwill
Goodwill
28351000
CY2018Q4 us-gaap Goodwill
Goodwill
CY2019Q3 us-gaap Gross Profit
GrossProfit
4520000
CY2018Q3 us-gaap Gross Profit
GrossProfit
3687000
us-gaap Gross Profit
GrossProfit
13385000
us-gaap Gross Profit
GrossProfit
9779000
CY2019Q3 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
1000000
CY2018Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
6548000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9316000
CY2018Q4 us-gaap Inventory Net
InventoryNet
3509000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1231000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10581000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2373000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-739000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-363000
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-291000
CY2018Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-43000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
377000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
343000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
372000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1678000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
558000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
205000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1730000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1064000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
87000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-98000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-11000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
272000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
49000
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16485000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
CY2019Q3 us-gaap Interest Expense
InterestExpense
1000
CY2018Q3 us-gaap Interest Expense
InterestExpense
1000
us-gaap Interest Expense
InterestExpense
5000
us-gaap Interest Expense
InterestExpense
4000
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3464000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1404000
CY2019Q3 us-gaap Inventory Net
InventoryNet
5694000
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1343000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1453000
CY2019Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
887000
CY2018Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
652000
CY2019Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1599000
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1284000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1625000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
556000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
868000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
201000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
101000
CY2019Q3 us-gaap Liabilities
Liabilities
7266000
CY2018Q4 us-gaap Liabilities
Liabilities
2319000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84228000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45467000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4944000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1939000
CY2018Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2019Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2247000
CY2018Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1657000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1329000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30294000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12997000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6339000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2216000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1763000
us-gaap Net Income Loss
NetIncomeLoss
10581000
us-gaap Net Income Loss
NetIncomeLoss
2373000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
9316000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
1231000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9316000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1151000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10581000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2094000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9913000
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9768000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-246000
us-gaap Notes Issued1
NotesIssued1
us-gaap Notes Issued1
NotesIssued1
18000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
5117000
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
2492000
us-gaap Operating Expenses
OperatingExpenses
12572000
us-gaap Operating Expenses
OperatingExpenses
7160000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-597000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1195000
us-gaap Operating Income Loss
OperatingIncomeLoss
813000
us-gaap Operating Income Loss
OperatingIncomeLoss
2619000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
160000
us-gaap Operating Lease Cost
OperatingLeaseCost
444000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1800000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1524000
CY2019Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
771000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
753000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
204000
us-gaap Operating Lease Payments
OperatingLeasePayments
576000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1300000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1177000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2019Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.065
CY2019Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y292D
CY2019Q3 us-gaap Other Income
OtherIncome
110000
CY2018Q3 us-gaap Other Income
OtherIncome
80000
us-gaap Other Income
OtherIncome
417000
us-gaap Other Income
OtherIncome
121000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
44000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
43000
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
1063000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
306000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
6000000
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
1000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
356000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
339000
CY2019Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
CY2018Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
80000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1309000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
20000000
CY2019Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
416000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
553000
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4434000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3647000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2136000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1319000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
9000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
10000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
279000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
855000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
353000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
312000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2420000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
983000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60450000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71031000
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6604000
CY2018Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5293000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19075000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14286000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1259000
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
725000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3035000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1978000
us-gaap Share Based Compensation
ShareBasedCompensation
1907000
us-gaap Share Based Compensation
ShareBasedCompensation
1131000
us-gaap Stock Issued1
StockIssued1
us-gaap Stock Issued1
StockIssued1
36000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
19932000
CY2019Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
19932000
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
36000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19915000
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19915000
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2018Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1394000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
794000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11724000
CY2018Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2825000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1063000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
43148000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
76962000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
46266000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
10092000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
43929000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
19655000
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5607748
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6383221
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5633702
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5522193
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25343112
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23656633
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24705424
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21051219
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19735364
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17273412
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19071722
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15529026

Files In Submission

Name View Source Status
0001437749-19-022475-index-headers.html Edgar Link pending
0001437749-19-022475-index.html Edgar Link pending
0001437749-19-022475.txt Edgar Link pending
0001437749-19-022475-xbrl.zip Edgar Link pending
bioli20190930_10q.htm Edgar Link pending
bioli20190930_10qimg001.gif Edgar Link pending
blfs-20190930.xml Edgar Link completed
blfs-20190930.xsd Edgar Link pending
blfs-20190930_cal.xml Edgar Link unprocessable
blfs-20190930_def.xml Edgar Link unprocessable
blfs-20190930_lab.xml Edgar Link unprocessable
blfs-20190930_pre.xml Edgar Link unprocessable
ex_163852.htm Edgar Link pending
ex_163853.htm Edgar Link pending
ex_163854.htm Edgar Link pending
ex_163855.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending